Exchange: NASDAQ·Updated 07:30 PM EDT
RIGL logo

RIGL Rigel Pharmaceuticals

$48.50
$0.92
(1.86%)
Today
Closed $48.50
$0.00
(0.00%)
After Hours
EarningsNov 3
Mkt Cap$923.16M
Vol190,390.00

About RIGL

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.
50

Neutral Sentiment

How do you feel about RIGL?

Advertisement|Remove ads.